Hypnion, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hypnion, Inc..The latest application filed is for "cns target modulators".
- Hypnion, Inc. - Indianapolis IN
- Hypnion, Inc. - Lexington MA
- Hypnion, Inc. - Worcester MA
Trademarks
| Patent | Date |
|---|---|
| Benzisoxazole piperidine compounds and methods of use thereof Grant 8,129,410 - Coughlin , et al. March 6, 2 | 2012-03-06 |
| Loxapine analogs and methods of use thereof Grant 8,101,596 - Edgar , et al. January 24, 2 | 2012-01-24 |
| Benzisoxazole piperazine compounds and methods of use thereof Grant 8,088,778 - Coughlin , et al. January 3, 2 | 2012-01-03 |
| Olanzapine analogs and methods of use thereof Grant 7,807,828 - Solomon , et al. October 5, 2 | 2010-10-05 |
| Loxapine analogs and methods of use thereof Grant 7,592,333 - Edgar , et al. September 22, 2 | 2009-09-22 |
| Quetiapine analogs and methods of use thereof Grant 7,563,785 - Edgar , et al. July 21, 2 | 2009-07-21 |
| Methods of treating sleep disorders Grant 7,524,864 - Edgar , et al. April 28, 2 | 2009-04-28 |
| Benzisoxazole piperazine compounds and methods of use thereof Grant 7,494,998 - Coughlin , et al. February 24, 2 | 2009-02-24 |
| Doxepin analogs and methods of use thereof Grant 7,482,460 - Edgar , et al. January 27, 2 | 2009-01-27 |
| Doxepin analogs and methods of use thereof Grant 7,411,069 - Edgar , et al. August 12, 2 | 2008-08-12 |
| Treatment of CNS disorders using CNS target modulators Grant 7,355,042 - Edgar , et al. April 8, 2 | 2008-04-08 |
| Doxepin analogs and methods of use thereof Grant 7,326,721 - Edgar , et al. February 5, 2 | 2008-02-05 |
| CNS target modulators Grant 7,317,026 - Edgar , et al. January 8, 2 | 2008-01-08 |
| Treatment of sleep disorders using CNS target modulators Grant 7,189,757 - Edgar , et al. March 13, 2 | 2007-03-13 |
| CNS target modulators App 20040142972 - Edgar, Dale M. ; et al. | 2004-07-22 |
| Treatment of sleeping disorders using CNS sleep target modulators App 20030232839 - Hangauer, David G. ; et al. | 2003-12-18 |
| Treatment of CNS disorders using CNS target modulators App 20030187021 - Edgar, Dale M. ; et al. | 2003-10-02 |
| SEC | 0001126024 | HYPNION INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 